Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry

AB0928 Psoriatic arthritis and biologic therapy: Treatment response, drug survival and outcome after switching – an observational study

(2014) D. Wallis et al.   ANNALS OF THE RHEUMATIC DISEASES

OP0168 Clinical response, drug survival and predictors thereof in 432 patients with ankylosing spondylitis switching anti tumor necrosis factor α therapy: Results from the danish nationwide danbio registry

(2014) B. Glintborg et al.   ANNALS OF THE RHEUMATIC DISEASES

A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the management of psoriatic arthritis

(2011) Zoe Ash et al.   ANNALS OF THE RHEUMATIC DISEASES

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

(2011) L Gossec et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

(2011) R. Gniadecki et al.   BRITISH JOURNAL OF DERMATOLOGY

Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) -- Report of the OMERACT 10 PsA Special Interest Group

(2011) L. C. COATES et al.   JOURNAL OF RHEUMATOLOGY

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

(2011) Suzanne Arends et al.   ARTHRITIS RESEARCH & THERAPY

Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry

(2010) B. Glintborg et al.   ANNALS OF THE RHEUMATIC DISEASES

Development of a preliminary composite disease activity index in psoriatic arthritis

(2010) A. Mumtaz et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry

(2010) Bente Glintborg et al.   ARTHRITIS AND RHEUMATISM

DANBIO--powerful research database and electronic patient record

(2010) M. L. Hetland   RHEUMATOLOGY

Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments

(2009) Annamaria Mazzotta et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

Psoriatic arthritis assessment and treatment update

(2009) Philip J Mease   CURRENT OPINION IN RHEUMATOLOGY

The Challenge and Need of Defining Axial Psoriatic Arthritis

(2009) J. L. FERNANDEZ-SUEIRO   JOURNAL OF RHEUMATOLOGY

An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, the Health Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions

(2009) David B. Schefte et al.   RHEUMATOLOGY

Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

(2009) Amr A Saad et al.   ARTHRITIS RESEARCH & THERAPY

Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry

(2008) M L Hetland et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment recommendations for psoriatic arthritis

(2008) C T Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

(2008) Marte Schrumpf Heiberg et al.   ARTHRITIS AND RHEUMATISM

Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab

(2008) Gerard Pitarch et al.   DERMATOLOGY